Minerva Neurosciences, Inc. (NERV)
NASDAQ·Healthcare·Biotechnology
$3.51
-7.74%
Mkt Cap $55.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+184.9%
Consensus $10.00 vs current $3.51
NASDAQ·Healthcare·Biotechnology
$3.51
-7.74%
Mkt Cap $55.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $10.00 – $10.00
+184.9%
Consensus $10.00 vs current $3.51